DENTSPLY SIRONA (NASDAQ:XRAY) Given New $25.00 Price Target at UBS Group
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) had its price objective dropped by research analysts at UBS Group from $27.00 to $25.00 in a report released on Friday,Benzinga reports. The firm currently has a “buy” rating on the medical instruments supplier’s stock. UBS Group’s target price points to a potential upside of 58.13% from the […]
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) had its price objective dropped by research analysts at UBS Group from $27.00 to $25.00 in a report released on Friday,Benzinga reports. The firm currently has a “buy” rating on the medical instruments supplier’s stock. UBS Group’s target price points to a potential upside of 58.13% from the […]
